Moderate

Chronic migraine prophylaxis and CGRP therapy

Preventive migraine treatment · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Preventive management of frequent episodic or chronic migraine (15 or more headache days per month) using oral prophylactics, botulinum toxin and CGRP-targeted therapies. Goal is to reduce frequency, severity and acute medication use.

Red flags

  • New or changing headache pattern
  • Papilloedema or focal neurological signs
  • Thunderclap component
  • Pregnancy on topiramate or candesartan
  • Worsening despite escalating acute medication (overuse)

Assessment

Differential diagnosis

  • Medication-overuse headache
  • Chronic tension-type headache
  • New daily persistent headache
  • Hemicrania continua
  • Idiopathic intracranial hypertension
  • Secondary headache (mass, venous thrombosis)

Investigations

  • Detailed headache diary quantifying monthly headache and acute-medication days
  • Assess for medication overuse
  • Examination including fundoscopy and blood pressure
  • Neuroimaging only if red flags or atypical features
  • Baseline mood and comorbidity screen
  • Pregnancy status before starting prophylaxis

Management

  • Confirm chronic migraine (15+ headache days/month, 8+ migrainous, for over 3 months)
  • Identify and treat coexisting medication-overuse headache first
  • Address lifestyle, sleep, hydration and trigger management
  • Start an oral preventive, choosing by comorbidity and tolerability
  • Titrate slowly and trial each agent at adequate dose for 8-12 weeks before judging
  • Offer botulinum toxin for chronic migraine failing oral agents
  • Offer CGRP monoclonal antibody or gepant after failure of appropriate oral preventives
  • Monitor response with headache diary and reduce acute medication reliance
  • Review contraception and pregnancy plans for teratogenic agents
  • Taper and stop effective preventives after sustained benefit where appropriate

Drugs & doses

Propranolol 80-160 mg PO daily (divided or modified-release)
Topiramate 25 mg PO nocte titrated to 50 mg BD
Amitriptyline 10-75 mg PO nocte
Candesartan 8-16 mg PO daily
OnabotulinumtoxinA 155-195 units IM over 31-39 sites every 12 weeks (chronic migraine)
Erenumab 70-140 mg SC monthly
Galcanezumab 240 mg SC loading then 120 mg SC monthly
Fremanezumab 225 mg SC monthly or 675 mg quarterly
Atogepant 60 mg PO daily; Rimegepant 75 mg PO every other day

Disposition

Outpatient neurology/headache clinic. Specialist referral for botulinum toxin and CGRP therapy where failure of standard preventives is documented.

Complications & pitfalls

  • Medication-overuse headache
  • Teratogenicity (topiramate, candesartan)
  • Topiramate cognitive and renal stone effects
  • Weight change and mood effects of preventives
  • Constipation with CGRP antibodies

Exam pearls

  • Treat medication overuse before judging preventive failure
  • CGRP therapies work even after multiple oral failures; access often requires documented prior trials
  • Topiramate reduces contraceptive efficacy and is teratogenic
  • Allow 8-12 weeks at target dose before declaring a preventive ineffective

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.